Trial intelligence / Profile preview

Dietary Supplements for COVID-19 Symptoms

NCT04780061Phase 3Terminated

Sponsor
Canadian College of Naturopathic Medicine
Start
Jul 2021
Primary completion
May 2022
Countries
1
01

Overview

Phase 3, randomised, double-blind trial (2 arms), sponsored by Canadian College of Naturopathic Medicine. Primary endpoint: Participant-reported Overall Health at 21 days. Started Jul 2021; status: terminated.

Beyond the preview

Go deeper on NCT04780061.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04780061.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call